Discontinued — last reported Q4 '25
Financing Cash Flow
FinancingEli Lilly Financing Cash Flow decreased by 642.1% to -$2.88B in Q4 2025 compared to the prior quarter. Over 3 years (FY 2021 to FY 2025), Financing Cash Flow shows an upward trend with a -18.8% CAGR.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryLeverage
SignalContext dependent
VolatilityModerate
First reportedQ1 2007
Last reportedQ4 2025
How to read this metric
A negative value (outflow) typically indicates the company is returning capital to shareholders or paying down debt, while a positive value indicates it is raising external capital.
Detailed definition
The total net flow of cash resulting from transactions with the company's owners and creditors. It aggregates activities...
Peer comparison
Highly profitable tech firms often show large negative financing cash flows due to aggressive share buyback programs.
Metric ID:
cf_net_cash_from_financingHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$1.08B | -$463.20M | -$1.53B | -$2.88B | -$123.70M | -$1.26B | -$1.14B | $412.30M | -$1.03B | $572.00M | $3.54B | -$311.30M | $1.56B | $211.30M | $1.38B | -$1.24B | $531.00M | -$2.88B |
| QoQ Change | — | +57.2% | -229.6% | -88.6% | +95.7% | -921.3% | +9.6% | +136.1% | -350.6% | +155.4% | +519.7% | -108.8% | +599.7% | -86.4% | +553.0% | -190.2% | +142.7% | -642.1% |
| YoY Change | — | — | — | — | +88.6% | -172.7% | +25.2% | +114.3% | -735.4% | +145.3% | +410.6% | -175.5% | +250.5% | -63.1% | +543.2% | -180.0% | +151.3% | — |
Range-$2.88B – $3.54B
CAGR+25.9%
Avg YoY Growth+30.9%
Median YoY Growth+88.6%
Financing Cash Flow at Other Companies
Frequently Asked Questions
- What is Eli Lilly's financing cash flow?
- Eli Lilly (LLY) reported financing cash flow of -$2.88B in Q4 2025.
- What is the long-term trend for Eli Lilly's financing cash flow?
- Over 3 years (2021 to 2025), Eli Lilly's financing cash flow has grown at a -18.8% compound annual growth rate (CAGR), from -$4.13B to -$2.21B.
- What does financing cash flow mean?
- The total amount of money moving in or out of the company to pay for its funding, including debt and shares.